NFE2L2 and atherosclerosis: Although little information exists on this SNP and its association with COVID-19, several studies have demonstrated the involvement of NFE2L2 polymorphisms, which encode the NRF2 transcription factor, in cases of atherosclerosis, bronchial asthma, and chronic obstructive pulmonary disease [23,24].